Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Piccoli

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bioanalysis|August 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for BiomarkersKaren J Quadrini, Jiri Aubrecht, Nicholas M P King, et al.
Lab on a Chip|December 10, 2016
Real-time observation of protein aggregates in pharmaceutical formulations using liquid cell electron microscopyLynn M DiMemmo, A Cameron Varano, Jonathan Haulenbeek, et al.
Bioanalysis|June 4, 2015
Anti-PEG antibody bioanalysis: a clinical case study with PEG-IFN-λ-1a and PEG-IFN-α2a in naive patientsHeather Myler, Matthew W Hruska, Subasree Srinivasan, et al.
The AAPS Journal|May 1, 2015
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein AssayYan G Ni, Xiling Yuan, John A Newitt, et al.
Scientific Reports|December 18, 2020
Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissuesPaul B Noto, Timothy W Sikorski, Francesca Zappacosta, et al.
Clinical Pharmacology and Therapeutics|January 4, 2025
Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic InjurySushrut S Waikar, Robin Mogg, Amanda F Baker, et al.
NPJ Parkinson'S Disease|February 3, 2026
Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled studyHarini Sarva, Rajesh Pahwa, Jorge Hernandez-Vara, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetesMelissa A Reed, Walter J Pories, William Chapman, et al.
The AAPS Journal|October 1, 2025
Why is Biomarker Assay Validation Different from that of Pharmacokinetic Assays?Yan G Ni, Lauren F Stevenson, Lakshmi Amaravadi, et al.
Bioanalysis|July 31, 2015
An integrated multiplatform bioanalytical strategy for antibody-drug conjugates: a novel case studyHeather Myler, Vangipuram S Rangan, Jian Wang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioanalysis|August 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for BiomarkersKaren J Quadrini, Jiri Aubrecht, Nicholas M P King, et al.
Lab on a Chip|December 10, 2016
Real-time observation of protein aggregates in pharmaceutical formulations using liquid cell electron microscopyLynn M DiMemmo, A Cameron Varano, Jonathan Haulenbeek, et al.
Bioanalysis|June 4, 2015
Anti-PEG antibody bioanalysis: a clinical case study with PEG-IFN-λ-1a and PEG-IFN-α2a in naive patientsHeather Myler, Matthew W Hruska, Subasree Srinivasan, et al.
The AAPS Journal|May 1, 2015
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein AssayYan G Ni, Xiling Yuan, John A Newitt, et al.
Scientific Reports|December 18, 2020
Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissuesPaul B Noto, Timothy W Sikorski, Francesca Zappacosta, et al.
Clinical Pharmacology and Therapeutics|January 4, 2025
Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic InjurySushrut S Waikar, Robin Mogg, Amanda F Baker, et al.
NPJ Parkinson'S Disease|February 3, 2026
Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled studyHarini Sarva, Rajesh Pahwa, Jorge Hernandez-Vara, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetesMelissa A Reed, Walter J Pories, William Chapman, et al.
The AAPS Journal|October 1, 2025
Why is Biomarker Assay Validation Different from that of Pharmacokinetic Assays?Yan G Ni, Lauren F Stevenson, Lakshmi Amaravadi, et al.
Bioanalysis|July 31, 2015
An integrated multiplatform bioanalytical strategy for antibody-drug conjugates: a novel case studyHeather Myler, Vangipuram S Rangan, Jian Wang, et al.
Pageof 2